Physician profile
Daniel G Petereit
NPI 1568457257
$6,359.75
in general payments reported to CMS, 2019-2025
38 companies · $1,338 in 2025
The $1,338 reported for 2025 was more than what 87% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,198 · 2020: $310 · 2021: $2,686 · 2022: $356 · 2023: $188 · 2024: $284 · 2025: $1,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,810.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,606.02 | 2019-2023 | Spaceoar System |
| Theragenics Corporation | $1,343.46 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $538.52 | 2021-2025 | Bravos Afterloader System, Truebeam |
| Elekta, INC. | $386.68 | 2019-2022 | |
| Arrow International, INC. | $143.64 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $135.06 | 2019-2025 | Imfinzi |
| Bioprotect Medical, INC. | $118.19 | 2024 | Bioprotect Balloon Implant System |
| Astellas Pharma US INC | $110.14 | 2023-2025 | Xtandi, Padcev |
| Janssen Biotech, INC. | $90.92 | 2019-2025 | Darzalex, Tecvayli, Talvey |
| Accuray Incorporated | $89.46 | 2021 | |
| Novartis Pharmaceuticals Corporation | $72.55 | 2019-2025 | |
| Pfizer INC. | $53.50 | 2025 | |
| Varian Medical Systems, INC. | $47.55 | 2020 | |
| Merck Sharp & Dohme LLC | $46.20 | 2019-2025 | Keytruda |
| Sirtex Medical INC | $46.10 | 2019-2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Petereit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.